Breaking Health Podcast
Candid Conversations with Digital Health Innovators & Business Leaders
Welcome to the Breaking Health Podcast
Conversations between VCs and entrepreneurs typically occur in boardrooms or coffee shops. In the Breaking Health Podcast, you get a seat at the table. Our hosts bring their investor insight to revealing conversations with the most disruptive CEOs in healthcare. Listen to understand how these leaders are building the companies – and fostering the cultures – that will change everything.
In this episode of Breaking Health, host Steve Krupa speaks with Matt Bettonville, investor at Yosemite, about the state of oncology research and his hunt for investments in discovery and treatment tools. Bettonville delves into the key to cancer treatment, where deals are flowing towards in the market, and how the AI revolution is helping with drug discovery and cancer treatment breakthroughs. He also discusses the complications (and frustrations) of making treatments affordable, finding new targets in primary cancers most frequently seen in the population, and the importance of early detection.
GUEST BIO
Matt Bettonville, Investor, Yosemite
Matt Bettonville is an Investor at Yosemite where he leads the team’s investment efforts in digital health and healthcare delivery. He previously worked on Emerson Collective’s Count Me In non-profit partnership with the Broad Institute. Matt started his career working on user interface software engineering at Apple, where he was on the Mac team and a part of the AirPods product team. He holds a B.S. in Computer Science from Stanford University with a focus in Human-Computer Interaction. Matt serves on the board of directors at Atropos, Maia Oncology, Turquoise Health, Count Me In and Getlabs. He serves as a board observer at Proximie.
Do You Have
A STORY TO TELL?
If you’d like to be considered as a guest on a future episode of the Breaking Health podcast, please complete the application today.
Meet Our Hosts
Stephen Krupa, HealthEdge, and Payal Agrawal Divakaran, .406 Ventures bring investor expertise to conversations with the most disruptive CEOs in healthcare.
Subscribe ON iTUNES
Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!
SUBSCRIBE ON iTUNES